Hospitals & Healthcare Pressreleases

This section covers the managerial aspects in the Healthcare industry.

NewLink Genetics to Participate in Three Upcoming Investor Conferences

Friday, October 30, 2015
GLOBE NEWSWIRE

AMES Iowa Oct 30 2015 GLOBE NEWSWIRE NewLink Genetics Corporation NASDAQNLNK a biopharmaceutical company at the forefront of developing and commercializing novel immunooncology product candidates to improve the lives of patients with cancer announced today that it will participate in three upc..

Portola Pharmaceuticals Completes Enrollment in Pivotal Phase 3 APEX Study of Betrixaban for Prevention of Blood Clots in Acute Medically Ill Patients

Friday, October 30, 2015
GLOBE NEWSWIRE

Company Expects to Report TopLine Results at End of First Quarter 2016 Betrixaban Has Potential to Become First Oral Factor Xa Inhibitor Anticoagulant Approved for Prevention of VTE in Acute Medically Ill SOUTH SAN FRANCISCO Calif Oct 30 2015 GLOBE NEWSWIRE Portola Pharmaceuticals NasdaqPTL..

Integra LifeSciences Receives Expanded Indication for CUSA® Excel+ System for Liver Surgery

Friday, October 30, 2015
GLOBE NEWSWIRE

PLAINSBORO NJ Oct 30 2015 GLOBE NEWSWIRE Integra LifeSciences Holding Corporation Nasdaq IART today announced that its CUSA Excel system is the first and only ultrasonic tissue ablation system cleared by the FDA for liver resection and tumor removal Previously cleared for a wide variety of sur..

Alphatec Spine Announces Retirement of James R. Glynn From Its Board of Directors; Donald A. Williams Appointed Audit Committee Chairman

Friday, October 30, 2015
GLOBE NEWSWIRE

CARLSBAD Calif Oct 30 2015 GLOBE NEWSWIRE Alphatec Holdings Inc NasdaqATEC the parent company of Alphatec Spine Inc a global provider of spinal fusion technologies announced today that James R Glynn is retiring as a member of the board of directors and Audit Committee Chairman effective Novemb..

Monte Johnston Honored by America\'s Registry as Bio of the Month of April 2016 in Automotive Sales and Management

Friday, October 30, 2015
PR Newswire

FARMINGDALE NY Oct 30 2015 PRNewswire Americas Registry of Outstanding Professionals has recognized Monte Johnston of Springdale Arkansas for his accomplishments in the field of Automotive Sales and Management Based on his achievements he has been selected as Bio of the Month of April 2016 inducte..

FairCare App Named In Top Three At The HealthTech Conference 2015

Friday, October 30, 2015
PR Newswire

SAN FRANCISCO Oct 30 2015 PRNewswire FairCare a medical big data startup based in Silicon Valley that has uncovered millions of medical prices nationwide was named in the Top 3 most promising companies at the 4th Annual HealthTech Conference on October 2728 2015 The startup shone among dozens of ..

Pediatrics Moves into the Concierge Medicine Spotlight: Parents and Physicians Increasingly Attracted to Personalized Care Model

Friday, October 30, 2015
PR Newswire

HIGHLAND PARK Ill Oct 30 2015 PRNewswire A pediatric practice that offers same day office appointments with little to no waiting time longer unhurried visits direct access to their own doctor day and nighta parents dream made real in the age of concierge medicine While the appeal of concierge ..

Mallinckrodt\'s INOmax® Approved In Australia And Japan For Pulmonary Hypertension In Conjunction With Heart Surgery

Friday, October 30, 2015
PR Newswire

CHESTERFIELD United Kingdom Oct 30 2015 PRNewswire Mallinckrodt plc NYSE MNK a leading specialty biopharmaceutical company today announced that INOmax nitric oxide for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conjunction with heart surgery IN..

U.S. District Court Denies Perrigo\'s Motion for Preliminary Injunction Related to Certain Mylan Disclosures

Friday, October 30, 2015
PR Newswire

HERTFORDSHIRE England and PITTSBURGH Oct 30 2015 PRNewswire Mylan NV Nasdaq MYL today announced that the US District Court for the Southern District of New York has denied the motion by Perrigo Company plc NYSE PRGO TASE for a preliminary injunction concerning Mylans proposed acquisition of Perri..

CVS Health Reports Record Third Quarter Results

Friday, October 30, 2015
PR Newswire

WOONSOCKET RI Oct 30 2015 PRNewswire Third Quarter Yearoveryear Highlights Net revenues increased 103 to 386 billion Operating profit increased 38 to 23 billion including the effect of acquisitionrelated transaction and integration costs of 127 million GAAP diluted EPS from continuing operat..

AbbVie Outlines Long-Term Strategic and Financial Objectives; Company Positioned for Strong Performance

Friday, October 30, 2015
PR Newswire

NORTH CHICAGO Ill Oct 30 2015 PRNewswire AbbVie NYSEABBV today outlined the companys longterm strategic and financial objectives including expectations for growth and other financial metrics over its longrange plan through 2020 AbbVie is wellpositioned to deliver strong top and bottomline perfor..

AbbVie Reports Third-Quarter 2015 Financial Results

Friday, October 30, 2015
PR Newswire

NORTH CHICAGO Ill Oct 30 2015 PRNewswire AbbVie NYSEABBV announced financial results for the third quarter ended September 30 2015 We are pleased with our outperformance in the third quarter and our progress yeartodate Weve driven strong commercial operational and RD execution resulting in indus..

China Cord Blood Corporation Guangdong Subsidiary Has Been Accredited by American Association of Blood Banks

Friday, October 30, 2015
PR Newswire

HONG KONG Oct 30 2015 PRNewswire China Cord Blood Corporation NYSE CO CCBC or the Company Chinas leading provider of cord blood collection laboratory testing hematopoietic stem cell processing and stem cell storage services today announced that the Companys Guangdong subsidiary Guangdong Cord Blo..

VolitionRx Schedules Third Quarter 2015 Earnings Conference Call and Business Update for Wednesday, November 4, 2015 at 8:30am ET

Friday, October 30, 2015
PR Newswire

NAMUR Belgium Oct 30 2015 PRNewswire VolitionRx Limited NYSE MKT VNRX a life sciences company focused on developing bloodbased diagnostic tests for a broad range of cancer types and other conditions today announced that in conjunction with the filing of its quarterly report on Form 10Q for th..

Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-FXI Rx in Patients with End-Stage Renal Disease on Hemodialysis

Friday, October 30, 2015
PR Newswire

CARLSBAD Calif Oct 30 2015 PRNewswire Isis Pharmaceuticals Inc NASDAQ ISIS announced the initiation of a Phase 2 study evaluating ISISFXIRx in patients with endstage renal disease ESRD on hemodialysis In May 2015 Isis entered into an exclusive license agreement with Bayer HealthCare Bayer to devel..

Mylan Third Quarter 2015 Constant Currency Adjusted Total Revenues Increase 36% and Adjusted Diluted EPS Increases 23% to $1.43

Friday, October 30, 2015
PR Newswire

HERTFORDSHIRE ENGLANDand PITTSBURGH Oct30 2015 PRNewswire Mylan NV Nasdaq MYL today announced its financial results for the quarter ended September30 2015 Third Quarter 2015 Highlights Adjusted total revenues of 271 billion up 36 on a constant currency basis versus the prior year period GAAP ..

Concordia Healthcare to Host Third Quarter 2015 Results Conference Call

Friday, October 30, 2015
PR Newswire

TORONTO Oct 30 2015 PRNewswire Concordia Healthcare Corp Concordia or the Company NASDAQ CXRX TSX CXR today announced it will release its third quarter 2015 financial results after market close on Thursday November 12 2015 The Company will subsequently hold a conference call on Friday November ..

Oasmia Pharmaceutical Receives Order of $7.5 Million in End-user Value for the Russian Market

Friday, October 30, 2015
PR Newswire

NEW YORK October 30 2015 PRNewswire Oasmia Pharmaceutical AB NASDAQ OASM FWB OMAX a developer of a new generation of drugs within human and veterinary oncology announced today that its distribution partner in Russia and the Commonwealth of Independent States CIS Pharmasyntez has placed its seco..

Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylan\'s Over-the-Counter Business

Friday, October 30, 2015
PR Newswire

HERTFORDSHIRE England and PITTSBURGH Oct 30 2015 PRNewswire Mylan NV Nasdaq MYL a leading global pharmaceutical company today announced the appointment of Ranjan Ray Chaudhuri to serve as global commercial lead of the companys overthecounter OTC business Chaudhuri will report to Rajiv Malik presi..

Former Deputy Attorney General Appointed To Advise Valeant\'s Ad Hoc Committee

Friday, October 30, 2015
PR Newswire

LAVAL Quebec Oct 30 2015 PRNewswire Valeant Pharmaceuticals International Inc NYSE VRX TSX VRX announced today that the ad hoc committee appointed by Valeants board of directors has appointed former Deputy Attorney General of the United States Mark Filip of Kirkland Ellis LLP to advise the commit..

TOP